Time.news – Moderna has announced the start of the development of a potential new vaccine that combines a booster against Covid-19 and a seasonal flu shot. “Today we announce the first step in our new respiratory vaccine program with the development of a single-dose vaccine that combines a booster against Covid-19 and a booster against influenza,” said Moderna CEO Stéphane Bancel.
“I am proud of the progress the Moderna team has made in moving forward with our mRNA vaccine development business while at the same time being committed to addressing the global Covid-19 pandemic. We are convinced that our mRNA platform can solve the world’s biggest health challenges, from diseases that affect millions of people, to ultra rare diseases, to personalized medicines up to the individual level “, said the number one of the pharmaceutical company.
In addition to the announcement on the new “combination” product, Moderna illustrated the progress “in enrolling patients in our rare disease programs for personalized cancer vaccine testing. We believe this is just the beginning of a new era of drugs based on the transmission of information “(between cells to produce antibodies, ed).
.